Norucholic acid for cholangitis, sclerosing

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Mar 2025: Trial registered, NCT06886360

The trials

NCT06886360: Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)

State
Not started
Phase
Phase 3
People
120 planned
Started
Mar 2025
Primary completion
Sep 2027
Arms
norucholic acid 1500 mg/day
Results
None posted
  1. 20 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.